Inter Pharma Stock

Equities

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E. 06:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
6.15 THB -2.38% Intraday chart for Inter Pharma -2.38% +11.04%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2022 1.53B 42.55M Sales 2023 1.8B 49.88M Capitalization 3.35B 92.98M
Net income 2022 119M 3.3M Net income 2023 50M 1.39M EV / Sales 2022 3.44 x
Net cash position 2022 238M 6.61M Net cash position 2023 13.3M 369K EV / Sales 2023 1.86 x
P/E ratio 2022
40.6 x
P/E ratio 2023
66 x
Employees -
Yield 2022
1.22%
Yield 2023
0.39%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024 CI
Inter Pharma Public Company Limited (SET:IP) agreed to acquire 70% stake in Metta Medtech Company Limited from Sittisak Phanitpotchaman for THB 130 million. CI
Inter Pharma Public Company Limited Proposes Dividend for the Year 2023, Payable on May 24, 2024 CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Inter Pharma Public Company Limited Announces Resignation of Mrs. Nattarin Polpuech as Director, Member of Risk Management Committee and Member of the Executive Committee CI
Inter Pharma Public Company Limited Announces CFO Changes CI
Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Inter Pharma Public Company Limited Approves Dividend for the Year 2022, Payable on May 26, 2023 CI
Inter Pharma Public Company Limited Approves Board Changes CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Inter Pharma Public Company Limited Announces Resignation of Terdkiat Prommool as Director CI
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
More news
1 day-2.38%
1 week-2.38%
Current month+0.95%
1 month+2.50%
3 months+16.21%
6 months+11.04%
Current year+11.04%
More quotes
1 week
6.10
Extreme 6.1
6.55
1 month
5.85
Extreme 5.8462
7.30
Current year
4.80
Extreme 4.8
7.30
1 year
4.80
Extreme 4.8
8.31
3 years
4.80
Extreme 4.8
14.95
5 years
1.62
Extreme 1.6176
15.14
10 years
1.62
Extreme 1.6176
15.14
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 14-03-31
Chief Operating Officer 49 17-06-13
Director/Board Member 54 22-07-19
Members of the board TitleAgeSince
Director/Board Member 54 21-02-07
Chairman 70 19-12-16
Chief Operating Officer 49 17-06-13
More insiders
Date Price Change Volume
24-05-17 6.15 -2.38% 218,132
24-05-16 6.3 +0.80% 93,891
24-05-15 6.25 -2.34% 198,390
24-05-14 6.4 +1.59% 279,860
24-05-13 6.3 0.00% 220,067

End-of-day quote Thailand S.E., May 16, 2024

More quotes
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
6.15
Average target price
-
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW